Andreas Toft Sørensen

Medicine & Life Sciences

1. Neuropeptide Y 100%
2. Optogenetics 98%
3. Seizures 83%
4. Neurons 80%
5. Hippocampus 75%
6. Dopaminergic Neurons 69%
7. Neuropeptide Y Receptors 66%
8. Epilepsy 53%
9. Dopamine 50%
10. Designer Drugs 49%
11. Synapses 49%
12. Action Potentials 34%
13. Stem Cells 32%
14. Neuronal Plasticity 31%
15. Psychology Transfer 31%
16. Neural Stem Cells 29%
17. neuropeptide Y2 receptor 29%
18. Psychological Inhibition 29%
19. Galanin 28%
20. Genes 28%
21. Ventral Tegmental Area 28%
22. neuropeptide Y C-terminal flanking peptide 27%
23. Natronomonas 26%
24. Synaptic Transmission 25%
25. preproneuropeptide Y 25%
26. Transgenes 24%
27. Microbial Rhodopsins 24%
28. Brain 24%
29. Genetic Therapy 22%
30. Chlorides 22%
31. Learning 21%
32. Light 20%
33. Transplants 20%
34. Halorhodopsins 20%
35. Long-Term Potentiation 19%
36. Neuropeptides 19%
37. In Vitro Techniques 19%
38. Interneurons 19%
39. Memory 19%
40. Cell- and Tissue-Based Therapy 18%
41. Channelrhodopsins 17%
42. Mesencephalon 17%
43. Neuroepithelial Cells 16%
44. Parkinson Disease 16%
45. Glutamic Acid 16%
46. Attention Deficit Disorder with Hyperactivity 15%
47. Temporal Lobe Epilepsy 15%
48. Induced Pluripotent Stem Cells 15%